Phase II Study to Establish Gene Expression Models Predicting Survival of Diffuse Large B-Cell Lymphoma Patients Treated With R-CHOP.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- 23 Jun 2017 Biomarkers information updated
- 18 Apr 2013 Planned End Date changed from 1 Dec 2012 to 1 Dec 2015 as reported by ClinicalTrials.gov.
- 31 Mar 2012 Additional lead trial investigator (Ash A Alizadeh) identified as reported by ClinicalTrials.gov.